Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells.

Extracellular adenosine regulates a wide variety of physiological processes by interacting with 4 adenosine receptor subtypes: A1, A2A, A2B, and A3. However, little is known of their pathophysiological roles in human cancers. In this study, we examined the expression pattern of adenosine receptors in various colorectal tissues and human colon carcinoma cell lines and investigated the biologic functions regarding colon carcinogenesis. Using reverse transcriptase polymerase chain reaction and Western blotting, we found that adenosine receptor A2B (ADORA2B) was consistently up-regulated in colorectal carcinoma tissues and colon cancer cell lines compared with normal colorectal mucosa. In immunohistochemistry, we observed diffuse immunopositivity of ADORA2B in 67% of colorectal adenocarcinomas (39/58), 17% of tubular adenomas (5/30), and 0% of normal colon glands (0/62). During a hypoxic state, there was also a significant induction of ADORA2B expression in the messenger RNA level at 8 hours of incubation and in the protein level at 24 hours of incubation in colon carcinoma cell lines. To examine the function of ADORA2B, we applied an ADORA2B-selective antagonist (MRS1754) to the colon carcinoma cells, which significantly inhibited cell growth in a dose-dependent manner as demonstrated with a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell proliferation assay. In conclusions, ADORA2B was overexpressed in colorectal carcinomas grown under a hypoxic state, presumably promoting cancer cell growth. Our data suggest that this adenosine receptor is a potential therapeutic target for colorectal cancer.

[1]  A. Scarpa,et al.  Pathology and Genetics , 2010 .

[2]  K. Varani,et al.  Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line , 2001, British journal of pharmacology.

[3]  J. Linden.  Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[4]  W. Malorni,et al.  Different pathways of apoptosis revealed by 2‐chloro‐adenosine and deoxy‐D‐ribose in mammalian astroglial cells , 1997, Journal of neuroscience research.

[5]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[6]  B. Fredholm,et al.  Adenosine receptors as targets for drug development. , 2003, Drug news & perspectives.

[7]  K. Fuxe,et al.  Adenosine receptor–dopamine receptor interactions in the basal ganglia and their relevance for brain function , 2007, Physiology & Behavior.

[8]  K. Jacobson,et al.  Emerging adenosine receptor agonists , 2007, Expert opinion on emerging drugs.

[9]  L. Heasley,et al.  Multiple signaling conduits regulate global differentiation‐specific gene expression in PC12 cells , 2004, Journal of cellular physiology.

[10]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[11]  J. Spychała.  Tumor-promoting functions of adenosine. , 2000, Pharmacology & therapeutics.

[12]  R. Cunha,et al.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. , 2008, Current pharmaceutical design.

[13]  X. Qu,et al.  Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. , 2008, Molecular immunology.

[14]  K. Varani,et al.  A glance at adenosine receptors: novel target for antitumor therapy. , 2003, Pharmacology & therapeutics.

[15]  F. Karami-Tehrani,et al.  Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors. , 2007, Oncology research.

[16]  D. Ferrari,et al.  Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells , 2001, British journal of pharmacology.

[17]  K. Jacobson,et al.  Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium , 2003, The Journal of experimental medicine.

[18]  A. Multani,et al.  Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor. , 2000, European journal of cancer.

[19]  T. Kondo,et al.  Expression of Human Pendrin in Diseased Thyroids , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[20]  Michele Zoli,et al.  Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors* , 2002, The Journal of Biological Chemistry.

[21]  L. Aaltonen,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[22]  R. Tarnuzzer,et al.  Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. , 1999, Circulation research.

[23]  J. Blay,et al.  Adenosine stimulation of proliferation of breast carcinoma cell lines: Evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro , 2004, Journal of cellular physiology.

[24]  K. Klotz,et al.  Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. , 2002, The Journal of investigative dermatology.

[25]  C. Ho,et al.  Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa. , 1996, Cancer letters.

[26]  P. Pacher,et al.  A2A receptors in inflammation and injury: lessons learned from transgenic animals , 2008, Journal of leukocyte biology.

[27]  E. Jackson,et al.  A2B Adenosine Receptors Stimulate Growth of Porcine and Rat Arterial Endothelial Cells , 2002 .

[28]  L. Zacharia,et al.  A2B Receptors Mediate the Antimitogenic Effects of Adenosine in Cardiac Fibroblasts , 2001, Hypertension.

[29]  I. Biaggioni,et al.  Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A2B Angiogenic Phenotype , 2004, Hypertension.

[30]  T. Nakazawa,et al.  Expression of CD73 and its ecto‐5′‐nucleotidase activity are elevated in papillary thyroid carcinomas , 2006, Histopathology.

[31]  P. Fishman,et al.  Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. , 1998, Cancer research.

[32]  K. Jacobson,et al.  Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.

[33]  G. Fisone,et al.  Adenosine A2A receptors and basal ganglia physiology , 2007, Progress in Neurobiology.

[34]  E. Oztaş,et al.  Novel neuroprotection by caffeine and adenosine A2A receptor antagonists in animal models of Parkinson's disease , 2006, Journal of the Neurological Sciences.